SYNTHESIS OF 1,3,4-OXADIAZOLES AS SELECTIVE T-TYPE CALCIUM CHANNEL INHIBITORS

Area of Science:

• Pharmacology
• Neuroscience
• Medicinal Chemistry

Background:

• Dysfunction of T-type calcium channels is linked to neuropathic pain, epilepsy, insomnia, and tremor.
• T-type calcium channels represent a potential therapeutic target for neurological disorders.

Purpose of the Study:

• To synthesize and evaluate novel 2,5-disubstituted 1,3,4-oxadiazole molecules as selective T-type calcium channel inhibitors.
• To identify a potential drug candidate for treating conditions associated with T-type calcium channel dysfunction.

Main Methods:

• A rational drug design approach was employed.
• A three-step synthetic strategy involved condensation, ring closing, and coupling reactions.
• Inhibition selectivity was assessed against Na+ and K+ channels in neuronal and HEK-293 cells.
• Efficacy was evaluated in a mouse model of seizure-induced death.

Main Results:

• 5-Chloro-N-(5-phenyl-1,3,4-oxadiazol-2-yl)thiophene-2-carboxamide (compound 11) was synthesized.
• Compound 11 demonstrated selective inhibition of T-type Ca2+ channels.
• Compound 11 suppressed seizure-induced death in a mouse model.
• Compound 11 showed selectivity over Na+ and K+ channels.

Conclusions:

• Compound 11 is a potent and selective T-type calcium channel inhibitor.
• Compound 11 serves as a valuable research tool for studying T-channel roles.
• This compound provides a foundation for developing new therapies for chronic neuropathic and inflammatory pain.